Ratings by UBS (Joon Lee)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/15/2026 | Ascendis Pharma | ASND | Maintain | Buy (Buy) |
|
Details | ||
| 10/15/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (Buy) |
|
Details | ||
| 10/15/2026 | uniQure BV | QURE | Maintain | Buy (Buy) |
|
Details | ||
| 10/15/2026 | PTC Therapeutics | PTCT | Maintain | Buy (Buy) |
|
Details | ||
| 10/15/2026 | Arrowhead Pharma | ARWR | Maintain | Buy (Buy) |
|
Details | ||
| 10/15/2026 | BridgeBio Pharma | BBIO | Maintain | Buy (Buy) |
|
Details | ||
| 10/14/2026 | Viking Therapeutic | VKTX | New Coverage | Buy (N/A) |
26.65 (25.17) |
-5.55% | Details |
